{
    "laboratory_examinations": [
        {
            "procedure_name": "Hemoglobin",
            "date": "Not specified",
            "findings": "Hemoglobin on admission was 56 g/L (normal range 138–172 g/dL).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Platelet Count",
            "date": "Not specified",
            "findings": "Platelet count was 240 × 10^9/L (normal range 150–450 × 10^9/L).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Prothrombin Time (PT)",
            "date": "Not specified",
            "findings": "PT was prolonged at 190.2 s (normal range 11–13.5 s).",
            "changes_over_time": "PT showed correction in mixing studies with pooled plasma."
        },
        {
            "procedure_name": "Activated Partial Thromboplastin Time (aPTT)",
            "date": "Not specified",
            "findings": "aPTT was prolonged at 144.9 s (normal range 21–35 s).",
            "changes_over_time": "aPTT showed correction in mixing studies with pooled plasma."
        },
        {
            "procedure_name": "Fibrin Degradation Product",
            "date": "Not specified",
            "findings": "Fibrin degradation product was 3.1 mg/L (normal <10 mg/L).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "D-dimer",
            "date": "Not specified",
            "findings": "D-dimer was 0.22 mg/L (normal <0.50 mg/L).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Fibrinogen",
            "date": "Not specified",
            "findings": "Fibrinogen level was increased to 5.6 g/L (normal range 2.0–4.0 g/L).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Factor X Level",
            "date": "Not specified",
            "findings": "Markedly reduced factor X levels to 4.7%.",
            "changes_over_time": "Factor X levels steadily improved to normalcy over three months."
        },
        {
            "procedure_name": "Bethesda factor X inhibitor titer assay",
            "date": "Not specified",
            "findings": "The Bethesda factor X inhibitor titer assay was negative.",
            "changes_over_time": "Not specified."
        }
    ]
}